| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Robert E. W. Hancock | Q53441913 |
| Suzana Straus | Q55117837 | ||
| P2860 | cites work | Laspartomycin, a new anti-staphylococcal peptide | Q72096063 |
| STUDIES ON TSUSHIMYCIN. I | Q78438452 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic | Q12187 |
| gram-positive bacteria | Q857288 | ||
| antimicrobial peptide | Q1201508 | ||
| P304 | page(s) | 1215-1223 | |
| P577 | publication date | 2006-03-03 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides | |
| P478 | volume | 1758 |
| Q40205283 | A broad-spectrum bactericidal lipopeptide with anti-biofilm properties |
| Q46920049 | A convenient solid-phase strategy for the synthesis of antimicrobial cyclic lipopeptides. |
| Q37263289 | A current perspective on daptomycin for the clinical microbiologist |
| Q40924758 | A dynamin-like protein involved in bacterial cell membrane surveillance under environmental stress |
| Q38563153 | A journey to the total synthesis of daptomycin |
| Q37713079 | A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus. |
| Q55339062 | A terpenoid isolated from sarang semut (Myrmecodia pendans) bulb and its potential for the inhibition and eradication of Streptococcus mutans biofilm. |
| Q60916150 | Action of Antimicrobial Peptides against Bacterial Biofilms |
| Q41103271 | Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms. |
| Q34648042 | Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies |
| Q48102108 | An Optimized Synthetic-Bioinformatic Natural Product Antibiotic Sterilizes Multidrug-Resistant Acinetobacter baumannii-Infected Wounds |
| Q33662096 | An efficient chemical synthesis of carboxylate-isostere analogs of daptomycin. |
| Q92782867 | Anti-Mycoplasma Activity of Daptomycin and Its Use for Mycoplasma Elimination in Cell Cultures of Rickettsiae |
| Q61814451 | Antibacterial Activities of Lipopeptide (C)₂-KKKK-NH₂ Applied Alone and in Combination with Lens Liquids to Fight Biofilms Formed on Polystyrene Surfaces and Contact Lenses |
| Q43128345 | Antibacterial activity of ultrashort cationic lipo-beta-peptides |
| Q54207896 | Antibiofilm Peptides and Peptidomimetics with Focus on Surface Immobilization. |
| Q40631566 | Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections |
| Q26991811 | Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance |
| Q34456773 | Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment |
| Q46685535 | Antifungal activity of Brevibacillus laterosporus JX-5 and characterization of its antifungal components |
| Q28077888 | Antimicrobial Peptides Targeting Gram-Positive Bacteria |
| Q35195248 | Antimicrobial activity of cationic peptides in endodontic procedures. |
| Q90568731 | Antimicrobial activity of linear lipopeptides derived from BP100 towards plant pathogens |
| Q89982262 | Antimicrobial activity of the quinoline derivative HT61 against Staphylococcus aureus biofilms |
| Q38183709 | Antimicrobial compounds from mangrove plants: A pharmaceutical prospective |
| Q92015465 | Antimicrobial efficacy and toxicity of novel CAMPs against P. aeruginosa infection in a murine skin wound infection model |
| Q37926863 | Antimicrobial peptides: promising alternatives to conventional antibiotics |
| Q46504703 | Antimicrobial properties and death-inducing mechanisms of saccharomycin, a biocide secreted by Saccharomyces cerevisiae. |
| Q91824292 | Antimicrobial sensing coupled with cell membrane remodeling mediates antibiotic resistance and virulence in Enterococcus faecalis |
| Q33826267 | Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model |
| Q36720179 | Bacterial Evasion of Host Antimicrobial Peptide Defenses |
| Q37874201 | Bacterial resistance mechanisms against host defense peptides |
| Q24682375 | Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells |
| Q55263222 | Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria. |
| Q92917314 | Biophysical approaches for exploring lipopeptide-lipid interactions |
| Q37285243 | Boosting antimicrobial peptides by hydrophobic oligopeptide end tags |
| Q37838487 | Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids |
| Q90470946 | Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids |
| Q36822969 | Cationic antimicrobial peptides disrupt the Streptococcus pyogenes ExPortal |
| Q37263514 | Causal role of single nucleotide polymorphisms within the mprF gene of Staphylococcus aureus in daptomycin resistance |
| Q34410541 | Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilis |
| Q34045376 | Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms |
| Q46240694 | Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics |
| Q42908495 | Characterization of the structure and membrane interaction of the antimicrobial peptides aurein 2.2 and 2.3 from Australian southern bell frogs. |
| Q33642703 | Chemical analysis, inhibition of biofilm formation and biofilm eradication potential of Euphorbia hirta L. against clinical isolates and standard strains. |
| Q28076261 | Colistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives |
| Q37547326 | Comparative Genome Analysis of the Daptomycin-Resistant Streptococcus anginosus Strain J4206 Associated with Breakthrough Bacteremia. |
| Q41226592 | Comparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine |
| Q34057457 | Comparative mechanistic studies of brilacidin, daptomycin, and the antimicrobial peptide LL16. |
| Q64063027 | Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa |
| Q35139449 | Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation. |
| Q50055239 | Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens |
| Q38895642 | Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients |
| Q58609304 | Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus dsp1 and asp23. |
| Q36295305 | Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity |
| Q42743421 | Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient |
| Q37417749 | Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains. |
| Q28754911 | Daptomycin versus Friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses |
| Q55114463 | Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial. |
| Q37762644 | Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery |
| Q34278802 | Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins |
| Q36864626 | Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia |
| Q34057475 | Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis |
| Q64121324 | Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides |
| Q36850184 | Detection of secreted antimicrobial peptides isolated from cell-free culture supernatant of Paenibacillus alvei AN5. |
| Q41382167 | Dual Mode of Action for Plusbacin A3 in Staphylococcus aureus. |
| Q43237186 | Early appropriate therapy of Gram-positive bloodstream infections: the conservative use of new drugs |
| Q46925250 | Effect of divalent cations on the structure of the antibiotic daptomycin. |
| Q37616543 | Elucidation of the Teixobactin Pharmacophore |
| Q33432726 | End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing |
| Q40228519 | Enhanced antibacterial efficacy of nitric oxide releasing thermoplastic polyurethanes with antifouling hydrophilic topcoats |
| Q49887078 | Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids |
| Q45413201 | Evaluation of morphological changes of Staphylococcus aureus and Escherichia coli induced with the antimicrobial peptide AN5-1. |
| Q34809662 | Evolution of antimicrobial peptides to self-assembled peptides for biomaterial applications |
| Q92192980 | Exploration of Nicotine Metabolism in Paenarthrobacter nicotinovorans pAO1 by Microbial Proteomics |
| Q36729066 | Explorations of catalytic domains in non-ribosomal peptide synthetase enzymology |
| Q53686599 | Failure of daptomycin to kill Staphylococcus aureus: impact of bacterial membrane fatty acid composition. |
| Q47130909 | Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure |
| Q27023447 | Functional linkage between genes that regulate osmotic stress responses and multidrug resistance transporters: challenges and opportunities for antibiotic discovery |
| Q39027556 | Gageostatins A-C, antimicrobial linear lipopeptides from a marine Bacillus subtilis. |
| Q60301193 | Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance |
| Q33768851 | Genetically engineered lipopeptide antibiotics related to A54145 and daptomycin with improved properties |
| Q34984662 | Genetics of antimicrobial resistance in Staphylococcus aureus. |
| Q33286644 | High-throughput synthesis and screening of cyclic peptide antibiotics |
| Q46525222 | Identification of a novel endophytic Bacillus sp. from Capsicum annuum with highly efficient and broad spectrum plant probiotic effect |
| Q28831485 | Identification of endophytic Bacillus mojavensis with highly specialized broad spectrum antibacterial activity |
| Q47316754 | In Silico Discovery of Novel Ligands for Antimicrobial Lipopeptides for Computer-Aided Drug Design |
| Q64075296 | In silico and Genetic Analyses of Cyclic Lipopeptide Synthetic Gene Clusters in Pseudomonas sp. 11K1 |
| Q42920252 | Incorporation of exogenous fatty acids protects Enterococcus faecalis from membrane-damaging agents |
| Q42178399 | Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif |
| Q90460333 | Influence of Short Cationic Lipopeptides with Fatty Acids of Different Chain Lengths on Bacterial Biofilms Formed on Polystyrene and Hydrogel Surfaces |
| Q92099546 | Interaction of Antimicrobial Lipopeptides with Bacterial Lipid Bilayers |
| Q30586516 | Interaction of daptomycin with lipid bilayers: a lipid extracting effect |
| Q45884525 | Interspecies interaction of signal peptide PapR secreted by Bacillus cereus and its effect on production of antimicrobial peptide |
| Q46967782 | Isolation and identification of a new intracellular antimicrobial peptide produced by Paenibacillus alvei AN5. |
| Q33681139 | Kinetic Analysis and Modeling of Daptomycin Batch Fermentation by Streptomyces roseosporus |
| Q38942573 | Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci |
| Q42738786 | Mechanism of action and limited cross-resistance of new lipopeptide MX-2401. |
| Q36276904 | Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition |
| Q92538088 | Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions |
| Q36565462 | Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall |
| Q33866571 | Membrane binding of an acyl-lactoferricin B antimicrobial peptide from solid-state NMR experiments and molecular dynamics simulations |
| Q53794393 | Metabolite and Mechanistic Basis of Antifungal Property Exhibited by Endophytic Bacillus amyloliquefaciens BmB 1. |
| Q30565890 | Minutissamides E-L, antiproliferative cyclic lipodecapeptides from the cultured freshwater cyanobacterium cf. Anabaena sp. |
| Q92252011 | Mode of action of the antimicrobial peptide Mel4 is independent of Staphylococcus aureus cell membrane permeability |
| Q35912731 | Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells. |
| Q53733143 | Molecular State of the Membrane-Active Antibiotic Daptomycin. |
| Q34794479 | Molecular determinants for the interaction of human neutrophil alpha defensin 1 with its propeptide |
| Q92703232 | More Than a Pore: A Current Perspective on the In Vivo Mode of Action of the Lipopeptide Antibiotic Daptomycin |
| Q34020547 | Multicomponent synthesis of acylated short peptoids with antifungal activity against plant pathogens |
| Q30795809 | NH125 kills methicillin-resistant Staphylococcus aureus persisters by lipid bilayer disruption |
| Q30788584 | New Insight into Daptomycin Bioavailability and Localization in Staphylococcus aureus Biofilms by Dynamic Fluorescence Imaging |
| Q57484501 | Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane |
| Q33713724 | Oligomeric structure of a cathelicidin antimicrobial peptide in dodecylphosphocholine micelle determined by NMR spectroscopy |
| Q36207578 | Peptoid Efficacy against Polymicrobial Biofilms Determined by Using Propidium Monoazide-Modified Quantitative PCR. |
| Q35860080 | Phylloseptin-PBa--A Novel Broad-Spectrum Antimicrobial Peptide from the Skin Secretion of the Peruvian Purple-Sided Leaf Frog (Phyllomedusa Baltea) Which Exhibits Cancer Cell Cytotoxicity. |
| Q53695580 | Plant Growth Enhancement, Disease Resistance, and Elemental Modulatory Effects of Plant Probiotic Endophytic Bacillus sp. Fcl1. |
| Q50497238 | Potent Antimicrobial Activity of Lipidated Short α,γ-Hybrid Peptides. |
| Q37897212 | Proteomic signatures in antibiotic research |
| Q21999339 | Purification and characterization of a novel lipopeptide from Streptomyces amritsarensis sp. nov. active against methicillin-resistant Staphylococcus aureus |
| Q40087009 | Recent advances in synthetic lipopeptides as anti-microbial agents: designs and synthetic approaches. |
| Q46251747 | Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies. |
| Q47107268 | Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure |
| Q35619094 | Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era |
| Q42772389 | Reversible daptomycin tolerance of adherent staphylococci in an implant infection model |
| Q33626330 | Screen for inducers of autolysis in Bacillus subtilis |
| Q38360418 | Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. |
| Q38507318 | Serine/threonine ligation for natural cyclic peptide syntheses. |
| Q90021198 | Short Cationic Peptidomimetic Antimicrobials |
| Q37875765 | Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action |
| Q50227889 | Staphylococcus aureus biofilm susceptibility to small and potent β(2,2)-amino acid derivatives. |
| Q33593317 | Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant (MDR) bacteria isolated from urinary tract infections (UTIs). |
| Q89075503 | Surfactin, Iturin, and Fengycin Biosynthesis by Endophytic Bacillus sp. from Bacopa monnieri |
| Q55024063 | Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers. |
| Q36126378 | Sustained Release of Antibacterial Lipopeptides from Biodegradable Polymers against Oral Pathogens. |
| Q50937911 | Synthesis, stability and mechanistic studies of potent anticryptococcal hexapeptides. |
| Q38698961 | Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors |
| Q35967862 | Synthetic Cyclolipopeptides Selective against Microbial, Plant and Animal Cell Targets by Incorporation of D-Amino Acids or Histidine |
| Q36904839 | Synthetic lipopeptides: a novel class of anti-infectives |
| Q33471277 | Synthetic ultrashort cationic lipopeptides induce systemic plant defense responses against bacterial and fungal pathogens |
| Q39392383 | Systematic study of non-natural short cationic lipopeptides as novel broad-spectrum antimicrobial agents |
| Q39413308 | Targeting a cell wall biosynthesis hot spot |
| Q36393640 | Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections |
| Q38191612 | The Interplay between Daptomycin and the Immune System |
| Q93271242 | The Mechanism of Membrane Permeabilization by Peptides: Still an Enigma |
| Q30886130 | The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion |
| Q46906605 | The insect pathogenic bacterium Xenorhabdus innexi has attenuated virulence in multiple insect model hosts yet encodes a potent mosquitocidal toxin |
| Q36773407 | The isotridecanyl side chain of plusbacin-A3 is essential for the transglycosylase inhibition of peptidoglycan biosynthesis |
| Q42140912 | The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate |
| Q35990126 | Thermodynamics of Micelle Formation and Membrane Fusion Modulate Antimicrobial Lipopeptide Activity. |
| Q34424198 | Thermodynamics of antimicrobial lipopeptide binding to membranes: origins of affinity and selectivity |
| Q52611146 | Towards the synthesis of sugar amino acid containing antimicrobial noncytotoxic CAP conjugates with gold nanoparticles and a mechanistic study of cell disruption. |
| Q36482900 | Transcriptional profiling reveals that daptomycin induces the Staphylococcus aureus cell wall stress stimulon and genes responsive to membrane depolarization |
| Q41989027 | Transgenic citrus expressing synthesized cecropin B genes in the phloem exhibits decreased susceptibility to Huanglongbing |
| Q92633929 | Ultrashort Cationic Lipopeptides-Effect of N-Terminal Amino Acid and Fatty Acid Type on Antimicrobial Activity and Hemolysis |
| Q39159453 | WH1fungin a surfactin cyclic lipopeptide is a novel oral immunoadjuvant |
| Q28740293 | Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus |
| Q35385108 | β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models |
Search more.